NCT05308524Unknown不适用
Role of Disease Severity Scoring Systems in Predicting Mortality covid19 Pts in AUH
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 70
- 主要终点
- ICU scoring system in covid 19
研究概览
简要总结
In this study, we planned to investigate the role and determine the predictive performance of both APACHE II and SAPS II scoring systems and compare them in COVID-19 patients admitted to the intensive care unit of Assiut University Hospital.
详细描述
Since the start of the coronavirus disease 2019 (COVID-19) pandemic, intensive care units (ICUs) worldwide have struggled to treat affected patients who require a completely different approach to treatment than other patients
- [1]* .This study aims to evaluate the efficacy of single dose analgesia in combination with local anaesthesia to control pain during TUS guided procedures. It also aims to assess the effect of its use on procedure performance time and rate of complications occurrence compared to local anaesthesia alone.Although many severe cases are admitted to ICUs, it is unknown whether the conventional disease-severity scoring systems that were developed for ICU patients can be applied to patients with COVID-19.Several recent studies have used Acute Physiology and Chronic Health Evaluation (APACHE) and Simplified Acute Physiology Score (SAPS) to provide information on the clinical severity of COVID-19
- [2-4]*. However, very few reports have examined their validity of applying them to patients with COVID-19.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •• This study will be conducted on laboratory-confirmed COVID-19 patients who will be transferred to the intensive care unit of Assiut University Hospital
排除标准
- •Patients would be excluded from this study if they died or were discharged from the intensive care unit prior collection of data required for both the APACHE II and SAPS II scoring systems, if they were discharged before their outcomes were determined and if we could not obtain consent from them or their companions to participate in this study. All patients involved will be subjected to a full history with special stress on age, gender, special habits, and associated diseases. Information such as the patient's need for ventilatory support as well as the length of ICU stay will be entered. Also, the laboratory results and Imaging findings will be registered. Scores of APACHE II and SAPS II were calculated as illustrated in the previously published works *[5,6]* .Patients will be followed up until their outcome was determined.
结局指标
主要结局
ICU scoring system in covid 19
时间窗: Baseline
SAPS ,APACHE ICU scoring system in covid 19
次要结局
未报告次要终点
研究者
Ebtesam Mohamed Thabet
resident doctor
Assiut University
相似试验
Unknown
不适用
COPD Scoring Systems in ICUCOPD Scoring SystemNCT05522322Assiut University195
进行中（未招募）
1 期
EVALUATION OF POTENTIAL PREDICTORS OF DISEASE PROGRESSION IN PATIENTS WITH aHUS, INCLUDING GENETICS, BIOMARKERS, ANDTREATMENTatypical Hemolytic-Uremic Syndrome (aHUS)MedDRA version: 19.1Level: LLTClassification code 10019515Term: Hemolytic uremic syndromeSystem Organ Class: 100000004851EUCTR2015-003135-35-DEAlexion Pharmaceuticals, Inc.330
进行中（未招募）
1 期
EVALUATION OF POTENTIAL PREDICTORS OF DISEASE PROGRESSION IN PATIENTS WITH aHUS, INCLUDING GENETICS, BIOMARKERS, AND TREATMENTatypical Hemolytic-Uremic Syndrome (aHUS)MedDRA version: 19.0Level: LLTClassification code 10019515Term: Hemolytic uremic syndromeSystem Organ Class: 100000004851EUCTR2015-003135-35-BEAlexion Pharmaceuticals, Inc.330
进行中（未招募）
1 期
EVALUATION OF POTENTIAL PREDICTORS OF DISEASE PROGRESSION IN PATIENTS WITH aHUS, INCLUDING GENETICS, BIOMARKERS, AND TREATMENTatypical Hemolytic-Uremic Syndrome (aHUS)MedDRA version: 19.1 Level: LLT Classification code 10019515 Term: Hemolytic uremic syndrome System Organ Class: 100000004851EUCTR2015-003135-35-GBAlexion Pharmaceuticals, Inc.67
已完成
不适用
Clinician JUdgment Versus Risk Score to Predict Stroke outComes: The JURASSIC Clinical TrialIschemic StrokeStrokeCerebrovascular DiseaseNCT01657279Unity Health Toronto111